Cogent Biosciences, Inc.: H.C. Wainwright raises target price to $56 from $55
COGT•H.C. Wainwright raised its target price for Cogent Biosciences to $56 from $55.
Related News
BMO cuts Gildan Activewear target price to $40 from $64
GIL•
Kaspi.kz 3Q 2026 net income reaches KZT 281 billion
KSPI•
Solaris receives USD 50 million final funding tranche from Royal Gold
RGLD•
Deutsche Bank raises Humana target price to $516 from $436
HUM•
BlackSky to participate in three investor conferences
BKSY•